NHTA is a proud ENCePP partner conducting PASS and regulatory-RWE studies with Nordic data. With deep scientific expertise, we help elevate the visibility of real-world evidence in regulatory decision-making.
Stay ahead with the latest from NHTA Insights and updates shaping the future of market access, HTA and evidence strategy.
Insights
Impact of JCA on Sweden’s HTA system?
At the SHEA conference in Linköping, NHTA hosted a panel on the EU JCA’s impact on Sweden’s HTA system. Experts from TLV, LIF, and NHTA stressed the importance of communication to avoid delays in patient access under the new joint assessment process.
